MedTrace Logo

Gender-Responsive Treatment for Women Offenders - 1

NCT00249613 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 291

Last updated 2014-04-07

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether substance abuse treatment designed specifically for drug-dependent women offenders provides better outcomes than standard drug court treatment (mixed-gender programs).

Conditions

  • Substance Abuse Problem

Interventions

BEHAVIORAL

Women-Only

Gender-responsive treatment for women only

Sponsors & Collaborators

Principal Investigators

  • Michael Prendergast, Ph.D. · University of California, Los Angeles

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-06-30
Primary Completion
2009-01-31
Completion
2009-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00249613 on ClinicalTrials.gov